The State of Data, Analytics, and AI in Commercial Biopharma
The State of Data, Analytics, and AI in Commercial Biopharma
12 PagesVeeva Nitro resolves the AI paradox in commercial biopharma by providing a common, reliable data foundation that accelerates analytics and AI adoption at scale. When a top pharmaceutical company's promising AI pilot stalled during rollout—due to prolonged algorithm development, market-specific failures, low field trust, and poor replication—Veeva unified fragmented data sources. It enabled consistent, trustworthy recommendations across markets, boosted field adoption, streamlined scaling, and delivered repeatable success for data-driven commercial strategies.
